Crucell Publishes First Quarter 2003 Results
14 avr. 2003 03h01 HE
|
Crucell N.V.
LEIDEN, The Netherlands, April 14, 2003 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today announced its financial results for the first quarter of 2003.
-...
Biora Year-End Report 2002
13 févr. 2003 06h11 HE
|
Biora
STOCKHOLM, Sweden, Feb. 13, 2003 (PRIMEZONE) -- Biora AB (publ) (Other OTC:BIORY)
4th Qtr 4th Qtr Full Year Full Year
2002 ...
Arexis: Patent Approval for Treating Common Skin Disorders
12 févr. 2003 05h10 HE
|
Arexis
STOCKHOLM, Sweden, Feb. 12, 2003 (PRIMEZONE) -- Arexis AB has received approval for a breakthrough patent application in Europe, covering a new method for treating the most common skin disorders. The...
Gyros AB Expands European Operations
21 oct. 2002 04h31 HE
|
Gyros
UPPSALA SCIENCE PARK, Sweden, Oct. 21, 2002 (PRIMEZONE) -- Gyros AB today announced the finalization of agreements with distributors, B & L Systems in BeNeLux and Bucher Biotec in Switzerland, to...
Innogenetics Announces Positive Liver Histology Results of Its Hepatitis C Therapeutic Vaccine
17 oct. 2002 03h51 HE
|
Innogenetics
GENT, Belgium, Oct. 17, 2002 (PRIMEZONE) -- Innogenetics (Other OTC:INGTF) today announced the first liver histology results of its E1-based therapeutic candidate vaccine in 24 patients chronically...
ING Initiates Coverage on Pharmexa with a Buy Recommendation
02 oct. 2002 08h32 HE
|
Pharmexa A/S
HOERSHOLM, Denmark, Oct. 2, 2002 (PRIMEZONE) -- Pharmexa A/S (Copenhagen:PHARMX) today announced that ING Financial Markets has initiated coverage of its stock. The research report, published today,...
Q-Med Appoints Acting Chief Financial Officer
24 sept. 2002 03h22 HE
|
Q-Med
UPPSALA, Sweden, Sept. 24, 2002 (PRIMEZONE) -- Erika Kjellberg Eriksson has been appointed acting Chief Financial Officer at Q-Med (Stockholm:QMED) and thereby replaces the former Chief Financial...
Nasdaq Life Sciences Investor Forum; Video Interview with Affymetrix
17 sept. 2002 06h14 HE
|
Cantos
LONDON, Sept. 17, 2002 (PRIMEZONE) -- Interview available now on www.cantos.com with Stephen P A Fodor, Affymetrix (Nasdaq:AFFX) Chairman and Chief Executive Officer.
Stephen tackles issues around...
Amersham: Video Interviews on Cantos
20 août 2002 02h38 HE
|
Cantos
OSLO, Norway, Aug. 20, 2002 (PRIMEZONE) -- Log on to http://www.cantos.com for: Amersham -- interim report.
-- Interviews with Sir William Castell, Amersham Chief Executive,
Dr. John...
Actelion Reports Positive RAPIDS-1 Results; Actelion Reports Highly Significant Study Results With Tracleer in Digital Ulcers
15 août 2002 01h53 HE
|
Actelion Ltd.
ALLSCHWIL/BASEL, Switzerland, Aug. 15, 2002 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) announced today preliminary results from RAPIDS-1, evaluating the efficacy and safety of Tracleer(TM) in the...